With an ever-changing landscape of gynecologic oncology, what are the latest trends in patient care and the profile of a women’s health care provider? SGO’s five-year benchmarking survey now includes input from gynecologic oncologists, advanced practice providers and international members. Hear from SGO past president, Barbara Goff, MD, and David Kushner, MD, on how the top findings from the survey translate into valuable practice implications.
AMA Credit Designation Statement – Physicians
The Society of Gynecology Oncology designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation on each activity.
ANCC Credit Designation Statement – Nurses
This activity has been approved for a maximum of 1.0 nursing contact hours.
PAs may claim a maximum of 1.0 AMA PRA Category 1 Credits™ for completing this live activity. NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state or medical society.
ACPE credit for pharmacists is not offered for this activity.
In order to assure the highest quality CE programming, SGO requires those who have the opportunity to affect the content of an educational activity to disclose financial relationship(s) with corporate interest(s). This condition must be met prior to participating in the CE activity. All conflicts of interest will be resolved prior to the start of the activity, per the SGO Conflict of Interest Resolution Policy. The following have indicated that no potential conflict(s) of interest exist.
Leslie Boyd, MD
Lee-may Chen, MD
Linus Chuang, MD
Barbara Goff, MD
Melissa Hardesty, MD
David Kushner, MD
Jason Lachance, MD
Joanne Rash, MPAS, PA-C
Shitanshu Uppal, MD, MBBS
Susan Zweizig, MD
The following have reported a relationship with a corporate interest, as listed, that may result in a conflict of interest. All potential conflict(s) of interest have been resolved through SGO’s Conflict of Interest Resolution Policy:
Elisabeth Diver, MD
Clovis Oncology/Advisory board member fee/Advisory board member
GlaxoSmithKline/advisory board fee; clinical trial funding/advisory board participation; site PI for national clinical trial
Aravive, Inc./ clinical trial funding/site PI for national clinical trial
Christina Annunziata, MD
Precision Biologics/Research grant/Principal Investigator
MaxCyte/Research grant/Principal Investigator
Robert Holloway, MD
Astra Zeneca/speaker fee/Speaker
Clovis/speaker fee, consultant fee/speaker, consultant
GSK/speaker fee/speaker fee, advisory board
Abbvie/ speaker fee/speaker, advisor
Bard-Davol/speaker fee /speaker
BJ Rimel, MD
Tesaro/GSK/consulting fee/Advisory board member